NKGen Biotech Company

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

Investors

Technology: Cell therapy
Industry: Private
Headquarters: Santa Ana, California, United States
Founded Date: 2017-01-01
Employees Number: 51-100
Funding Status: Seed
Investors Number: 1
Total Funding: 11000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-12-17
Last Funding Type: Seed

Visit Website
info@nkgenbiotech.com
https://twitter.com/nkgenbiotech
Register and Claim Ownership